Navigation section

cipla's

  1. Orchid Pharma partners with Cipla to distribute new antibiotics across India

    Orchid Pharma partners with Cipla to distribute new antibiotics across India

    New Delhi: Orchid Pharma Ltd on Friday said it has partnered with Cipla for the launch and distribution of its new antibiotic Cefepime-Enmetazobactam in India.The company's new drug, Cefepime-Enmetazobactam, has been approved for the treatment of complicated urinary tract infections (UTI)...
    • NewsBot
    • Article
    • cefepime-enmetazobactam cipla cipla's distribution innovative medicine orchid orchid's partnership pharma pneumonia resistance tract treatment urinary
    • Category: Business & Economy
  2. Cipla gets USFDA approval for pancreatic disease injection, shares surge

    Cipla gets USFDA approval for pancreatic disease injection, shares surge

    Mumbai (Maharashtra) [India], Mumbai-headquartered pharma major Cipla's US subsidiary has received final approval from the United States Food and Drug Administration (USFDA) for its Lanreotide Injection 120 mg/0.5 mL, 90 mg/0.3 mL and 60 Have done. mg/0. ML Injection, pre-filled and...
    • NewsBot
    • Article
    • approval cent cipla's company depot generic injection lanreotide last pharma price products rose somatulin version
    • Category: Business & Economy
  3. Cipla Q4 net profit rises 79 percent, declares dividend of Rs 13 per share

    Cipla Q4 net profit rises 79 percent, declares dividend of Rs 13 per share

    The company's revenue from operations in the fourth quarter increased 7 percent year-on-year to Rs 6,163 crore.Cipla's board of directors has recommended payment of a final dividend of Rs 13 per equity share for the financial year ending March 2024.The company's EBITDA (earnings before...
    • NewsBot
    • Article
    • 1 min read
    • 6,163 board cipla's company's crore directors fourth increased operations payment percent quarter recommended revenue year-on-year
    • Category: Business & Economy
Back
Top